Sg Americas Securities, LLC Atreca, Inc. Transaction History

Sg Americas Securities, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$1.61 - $5.2 $17,104 - $55,244	-10,624 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$2.87 - $6.29 $44,183 - $96,834	-15,395 Reduced 59.17%	10,624 $32,000
Q3 2021 Nov 01, 2021	BUY	$4.91 - $9.07 $127,753 - $235,992	26,019 New	26,019 $162,000
Q2 2021 Aug 12, 2021	SELL	$7.82 - $13.8 $58,759 - $103,693	-7,514 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$13.0 - $19.34 $97,682 - $145,320	7,514 New	7,514 $115,000
Q3 2020 Nov 09, 2020	SELL	$12.67 - $23.19 $147,314 - $269,630	-11,627 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$12.52 - $23.45 $61,723 - $115,608	4,930 Added 73.62%	11,627 $247,000
Q1 2020 Apr 30, 2020	BUY	$11.4 - $27.28 $76,345 - $182,694	6,697 New	6,697 $111,000
Q3 2019 Nov 04, 2019	SELL	$10.42 - $22.04 $153,174 - $323,988	-14,700 Closed	0 $0
Q2 2019 Jul 29, 2019	BUY	$17.07 - $18.84 $250,929 - $276,948	14,700 New	14,700 $277,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.